Introduction

Patellofemoral osteoarthritis (OA) is a specific type of knee arthritis that affects the joint where the kneecap meets the thigh bone. Unlike more general knee OA, this form often causes distinct challenges, especially during activities that bend or load the front of the knee. Many people with patellofemoral OA find everyday movements—such as climbing stairs, walking uphill, squatting, or cycling—uncomfortably painful due to kneecap pain. Recently, Arthrosamid has gained attention as a promising and evidence-supported treatment option that aims to ease this discomfort. In this article, we’ll take a closer look at how Arthrosamid works for patellofemoral OA and what patients and clinicians need to know.

Understanding Patellofemoral Osteoarthritis

Patellofemoral osteoarthritis involves wear and tear of the cartilage within the joint between the kneecap (patella) and the thigh bone (femur). This joint is crucial for smooth knee movement and helps distribute forces when the knee bends. Unlike other types of knee OA that mostly affect areas further down the joint, patellofemoral OA causes pain specifically around or behind the kneecap.

Typical symptoms include sharp or dull pain when going up or down stairs, discomfort when squatting, difficulty with cycling, and tenderness when pressing on the kneecap. These symptoms can seriously impact daily life, making it essential to have treatments that focus precisely on this joint and its unique stresses.

Arthrosamid: How It Works and Its Benefits

Arthrosamid is an injectable polyacrylamide hydrogel designed to cushion the joint. When it is injected into the patellofemoral compartment, it acts like a shock absorber, helping to reduce friction and ease pain by supplementing worn cartilage.

Clinical studies have shown that Arthrosamid can improve joint comfort and mobility, especially during activities that strain the kneecap, such as squatting, using stairs, or cycling. Importantly, research states that “Arthrosamid® has been known to be safe and efficacious in knee osteoarthritis (OA) patients” (Gao et al., 2025a). The gel moves with the joint, distributing loads more evenly to help functional movement.

It’s worth noting that while many patients benefit, results can vary between individuals. Scientists continue to explore “which patient factors would allow Arthrosamid to provide the most clinical benefit in a knee OA patient” (Gao et al., 2025a). This means Arthrosamid is best seen as part of a wider treatment plan, tailored to each person.

What to Consider Before Treatment: Expertise and Support

Deciding whether Arthrosamid is appropriate involves careful assessment by a specialist to ensure it fits the patient’s specific needs and goals. Clinicians weigh up various factors to select those most likely to respond well to this treatment.

Professor Paul Lee, a recognised cartilage expert and Regional Surgical Ambassador for the Royal College of Surgeons of Edinburgh, leads the London Cartilage Clinic where Arthrosamid treatments are offered. The clinic’s approach is professional and patient-centred, combining advanced treatments with thorough assessments and rehabilitation support.

This holistic philosophy ensures patients receive the best possible care designed around their individual joint health.

Patient Experiences and What to Expect

Patients at the London Cartilage Clinic typically undergo a thorough assessment before having the Arthrosamid injection, which is carried out under expert care. Recovery tends to be smooth, with many reporting less kneecap pain and improved ease of movement in everyday tasks.

People often notice a difference when squatting, climbing stairs, or cycling, leading to a better quality of life and more independence. However, responses do differ, emphasising the value of personalised treatment and monitoring.

Current research reminds us that “the literature surrounding which patients would incur the most benefit from Arthrosamid is limited” (Gao et al., 2025a), reinforcing the necessity for expert guidance throughout the process.

Conclusion

Patellofemoral osteoarthritis is a challenging condition that can seriously affect daily mobility and comfort. Arthrosamid offers a novel and targeted option that may ease kneecap pain and enhance function for many patients.

With the expert care provided by specialists like Professor Paul Lee and the supportive environment at the London Cartilage Clinic, patients can explore this treatment with confidence. For those considering Arthrosamid, a specialist assessment is essential to ensure the best possible results.

As always, for personal medical advice, please speak to a qualified healthcare professional.

References

• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., Verma, T., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma. https://doi.org/10.1016/j.jcot.2025.103136
• Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., & Lee, P. Y. F. (2025a). The impact of patient factors on the minimal clinically important difference of Arthrosamid polyacrylamide hydrogel injection for knee osteoarthritis: A cohort study. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.02.648